X4 Pharmaceuticals XFOR Stock Chart Pattern Insight X4 Pharmaceuticals posts 379 EPS beat with narrower loss MSBIP Midland tops Q1 2026 EPS estimates by 245 percent shares notch mild gains on investor optimism New NFE Stock Valuation Gap Analysis Q4 2025 Profit Surprises